Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-20T19:55:34.307Z Has data issue: false hasContentIssue false

Chapter 15 - Treatment Options for Hypertension in Pregnancy

from Section 4 - Cardiovascular Therapies

Published online by Cambridge University Press:  28 April 2018

By
Lin Fung Foo ,
Jasmine Tay  and
Ian Wilkinson
Edited by
Christoph Lees  and
Wilfried Gyselaers
Christoph Lees
Affiliation:
Imperial College London
Wilfried Gyselaers
Affiliation:
Hasselt Universiteit, Belgium
Get access
Type
Chapter
Information
Maternal Hemodynamics , pp. 141 - 160
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Say, L, Chou, D, Gemmill, A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health, 2014;2(6):e323–33.CrossRefGoogle ScholarPubMed
Lindheimer, MD, Taler, SJ, Cunningham, FG. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich), 2009;11(4):214–25.CrossRefGoogle ScholarPubMed
Lo, JO, Mission, JF, Caughey, AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol, 2013;25(2):124–32.CrossRefGoogle ScholarPubMed
Foo, L, Bewley, S, Rudd, A. Maternal death from stroke: a thirty year national retrospective review. Eur J Obstet Gynecol Reprod Biol, 2013;171(2):266–70.CrossRefGoogle ScholarPubMed
National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol, 2000;183(1):S1–S22.CrossRefGoogle Scholar
NICE. National Institute for Health and Clinical Excellence: (CG107) Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. 2011: London.Google Scholar
Paruk, F, Moodley, J. Untoward effects of rapid-acting antihypertensive agents. Best Pract Res Clin Obstet Gynaecol, 2001;15(4):491–506.Google Scholar
Redman, C. Hypertension, in Medical disorders in obstetric practice, Swiet, M.de, Editor. 2002, Blackwell Publishing Company.159–197.CrossRefGoogle Scholar
Tranquilli, AL, Dekker, G, Magee, L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens, 2014;4(2):97–104.CrossRefGoogle ScholarPubMed
Sibai, BM, Ewel, M, Levine, RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol, 1997;177(5):1003–10.CrossRefGoogle ScholarPubMed
Ghosh, G, Grewal, J, Männistö, T, et al. Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. Ethn Dis, 2014;24(3):283–9.Google ScholarPubMed
Chaturvedi, N, McKeigue, PM, Marmot, MG. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension, 1993;22(1):90–6.CrossRefGoogle ScholarPubMed
Valensise, H, Novelli, GP, Vasapollo, B. Pre-eclampsia: One name, two conditions – the case for early and late disease being different. Fetal Matern Med Rev, 2014;24:32–7.Google Scholar
Ferrazzi E, ST, Aupont, JE. The evidence for late-onset pre-eclampsia as a maternogenic disease of pregnancy. Fetal Matern Med Rev, 2013; 24(1):18–31.CrossRefGoogle Scholar
Huppertz, B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension, 2008; 51(4):970–5.Google Scholar
Sibai, B, Dekker, G, Kupferminc, M. Pre-eclampsia. Lancet, 2005;365(9461):785–99.CrossRefGoogle ScholarPubMed
Levine, RJ, Lam, C, Qian, C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 2006;355(10):992–1005.CrossRefGoogle ScholarPubMed
Levine, RJ, Maynard, SE, Qian, C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004;350(7):672–83.Google Scholar
Xiong, X, Demianczuk, NN, Saunders, LD, Wang, FL, Fraser, WD Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol, 2002;155(3):203–9.CrossRefGoogle ScholarPubMed
Ananth, CV, Peltier, MR, Kinzler, WL, Smulian, JC, Vintzileos, AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol, 2007;197(3):273 e1–7.CrossRefGoogle ScholarPubMed
Haelterman, E, Bréart, G, Paris-Llado, J, Dramaix, M, Tchobroutsky, C. Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. Am J Epidemiol, 1997;145(8):689–95.Google Scholar
Walfisch, A, Al-maawali, A, Moretti, ME, Nickel, C, Koren, G. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol, 2011;31(6):465–72.Google Scholar
Piper, JM, Ray, WA, Rosa, FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol, 1992;80(3 Pt 1):429–32.Google Scholar
Rosa, FW, Bosco, LA, Graham, CF, Milstien, JB, Dreis, M, Creamer, J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol, 1989;74(3 Pt 1):371–4.Google Scholar
Kincaid-Smith, P, Bullen, M, Mills, J. Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J, 1966;1(5482):274–6.CrossRefGoogle ScholarPubMed
Ananth, CV, Savitz, DA, Bowes, WA, Luther, ER. Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. Br J Obstet Gynaecol, 1997;104(5):572–8.CrossRefGoogle ScholarPubMed
Romero-Arauz, JF, Ortiz-Diaz, CB, Leaños-miranda, A, Martinez-Rodriguez, OA. Progression of gestational hypertension to preeclampsia. Ginecol Obstet Mex, 2014;82(4):229–35.Google ScholarPubMed
Anumba, DO, Lincoln, K, Robson, SC. Predictive value of clinical and laboratory indices at first assessment in women referred with suspected gestational hypertension. Hypertens Pregnancy, 2010;29(2):163–79.Google Scholar
Villar, J, Carroli, G, Wojdyla, D, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol, 2006;194(4):921–31.CrossRefGoogle ScholarPubMed
Buchbinder, A, Sibai, BM, Caritis, S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol, 2002;186(1):66–71.Google Scholar
Steer, PJ, Little, MP, Kold-Jensen, T, Chapple, J, Elliott, P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ, 2004;329(7478):1312.CrossRefGoogle ScholarPubMed
Al Khaja, KAJ, Sequeira, P, Alkhaja, AK, Damanhori, AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens, 2014;32(3):454–63.Google Scholar
Mutch, LM, Moar, VA, Ounsted, MK, Redman, CW. Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life. Early Hum Dev, 1977;1(1):59–67.CrossRefGoogle ScholarPubMed
Cockburn, J, Moar, VA, Ounsted, M, Redman, CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet, 1982;1(8273):647–9.Google Scholar
el-Qarmalawi, AM, Morsy, AH, al-Fadly, A, Obeid, A, Hashem, M. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension. Int J Gynaecol Obstet, 1995. 49(2):125–30.CrossRefGoogle ScholarPubMed
Huisjes, HJ, Hadders-Algra, M, Touwen, BC. Is clonidine a behavioural teratogen in the human? Early Hum Dev, 1986. 14(1):43–8.Google Scholar
Chobanian, AV, Bakris, GL, Black, HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003;289(19):2560–72.Google Scholar
Butters, L, Kennedy, S, Rubin, PC. Atenolol in essential hypertension during pregnancy. BMJ, 1990;301(6752):587–9.CrossRefGoogle ScholarPubMed
Lip, GY, Beevers, M, Churchill, D, Shaffer, LM, Beevers, DG. Effect of atenolol on birth weight. Am J Cardiol, 1997;79(10):1436–8.Google Scholar
Yakoob, MY, Bateman, BT, Ho, E, et al. The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a meta-analysis. Hypertension, 2013;62(2):375–81.Google Scholar
Sorensen, HT, Czeizel, AE, Rockenbauer, M, Steffensen, FH, Olsen, J. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand, 2001;80(5):397–401.Google Scholar
Danielsson, BR, Reiland, S, Rundgvist, E, Danielson, M. Digital defects induced by vasodilating agents: relationship to reduction in uteroplacental blood flow. Teratology, 1989;40(4):351–8.CrossRefGoogle ScholarPubMed
Scott, WJ, Jr., Resnick, E, Hummler, H, Clozel, JP, Bürgin, H. Cardiovascular alterations in rat fetuses exposed to calcium channel blockers. Reprod Toxicol, 1997;11(2–3):207–14.CrossRefGoogle ScholarPubMed
Brown, MA, Buddle, ML, Farrell, T, Davis, GK. Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. Am J Obstet Gynecol, 2002;187(4):1046–50.Google Scholar
Impey, L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol, 1993;100(10):959–61.Google Scholar
Papatsonis, DN, Lok, CA, Bos, JM, Geijn, HP, Dekker, GA. Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol, 2001;97(2):122–40.Google Scholar
Ben-Ami, M, Giladi, Y, Shalev, E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol, 1994;101(3):262–3.Google Scholar
Ales, K. Magnesium plus nifedipine. Am J Obstet Gynecol, 1990;162(1):288.Google Scholar
Magee, LA, Miremadi, S, Li, J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol, 2005;193(1):153–63.Google Scholar
Vasilakis-Scaramozza, C, Aschengrau, A, Cabral, HJ, Jick, SS. Antihypertensive drugs and the risk of congenital anomalies. Pharmacotherapy, 2013;33(5):476–82.Google ScholarPubMed
Cooper, WO, Hernandez-Diaz, S, Arbogast, PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med, 2006;354(23):2443–51.Google Scholar
Quan, A, Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev, 2006;82(1):23–8.Google Scholar
Alwan, S, Polifka, JE, Friedman, JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol, 2005;73(2):123–30.Google Scholar
Groves, TD, Corenblum, B. Spironolactone therapy during human pregnancy. Am J Obstet Gynecol, 1995;172(5):1655–6.Google Scholar
Spinnato, JA, Sibai, BM, Anderson, GD. Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension. South Med J, 1986;79(5):559–62.CrossRefGoogle ScholarPubMed
Paterson-Brown, S, Robson, SC, Redfern, N, Walkinshaw, SA, de Swiet, M. Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. Br J Obstet Gynaecol, 1994;101(5):409–13.CrossRefGoogle ScholarPubMed
Davis, RL, Eastman, D, McPhillips, H, et al. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf, 2011;20(2):138–45.CrossRefGoogle ScholarPubMed
Olsen, KS, Beier-Holgersen, R. Hemodynamic collapse following labetalol administration in preeclampsia. Acta Obstet Gynecol Scand, 1992;71(2):151–2.Google Scholar
Magee, LA, Cham, C, Waterman, EJ, Ohlsson, A, von Dadelszen, P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ, 2003;327(7421):955–60.Google Scholar
Vigil-De Gracia, P, Lasso, M, Ruiz, E, Vega-Malek, JC, de Mena, FT, Lopez, JC. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol, 2006;128(1–2):157–62.Google Scholar
Duley, L, Henderson-Smart, DJ, Meher, S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev, 2006;3:CD001449.Google Scholar
Firoz, T, Magee, LA, MacDonnell, K, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG, 2014;121(10):1210–8; discussion 1220.CrossRefGoogle ScholarPubMed
Rumbold, AR, Crowther, CA, Haslam, RR, Dekker, GA, Robinson, JS. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med, 2006;354(17):1796–806.Google Scholar
Poston, L, Briley, AL, Seed, PT, Kelly, FJ, Shennan, AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet, 2006;367(9517):1145–54.Google Scholar
Conde-Agudelo, A, Romero, R, Kusanovic, JP, Hassan, SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 2011;204(6):503.Google Scholar
Basaran, A, Basaran, M, Topatan, B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv, 2010;65(10):653–67.Google Scholar
Romero, R, Garite, TJ. Unexpected results of an important trial of vitamins C and E administration to prevent preeclampsia. Am J Obstet Gynecol, 2006;194(5):1213–4.Google Scholar
Banerjee, S, Chambers, AE, Campbell, S. Is vitamin E a safe prophylaxis for preeclampsia? Am J Obstet Gynecol, 2006;194(5):1228–33.CrossRefGoogle ScholarPubMed
Ramsay, B, De Belder, A, Campbell, S, Moncada, S, Martin, JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. Eur J Clin Invest, 1994;24(1):76–8.Google Scholar
Manzur-Verástegui, S, Mandeville, PB, Gordillo-Moscoso, A, Hernández-Sierra, JF, Rodríguez-Martínez, M. Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial. Clin Exp Pharmacol Physiol, 2008;35(5–6):580–5.Google Scholar
Cetin, A, Yurtcu, N, Guvenal, T, Imir, AG, Duran, B, Cetin, M. The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia. Hypertens Pregnancy, 2004;23(1):37–46.Google Scholar
Lees, C, Valensise, H, Black, R, et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound Obstet Gynecol, 1998;12(5):334–8.Google Scholar
Schleussner, E, Lehmann, T, Kähler, C, Schneider, U, Schlembach, D, Groten, T. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial. J Perinat Med, 2014;42(4):507–14.Google Scholar
de Belder, A, Lees, C, Martin, J, Moncada, S, Campbell, S. Treatment of HELLP syndrome with nitric oxide donor. Lancet, 1995;345(8942):124–5.Google Scholar
Lees, C, Langford, E, Brown, AS, et al. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstet Gynecol, 1996;88(1):14–9.CrossRefGoogle ScholarPubMed
Khalil, A, Akolekar, R, Syngelaki, A, Elkhouli, M, Nicolaides, KH. Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol, 2012;40(1):28–34.Google Scholar
Everett, TR, Wilkinson, IB, Mahendru, AA, et al. S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia. Br J Clin Pharmacol, 2014;78(3):660–9.Google Scholar
Hernandez-Diaz, S, Toh, S, Cnattingius, S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ, 2009;338:b2255.Google Scholar
Basso, O, Christensen, K, Olsen, J. Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? Epidemiology, 2001;12(6):624–9.Google Scholar
Hargood, JL, Brown, MA. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust, 1991;154(6):376–7.Google Scholar
Trogstad, L, Skrondal, A, Stoltenberg, C, Magnus, P, Nesheim, BI, Eskild, A. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A, 2004;126A(1):41–5.Google Scholar
Facchinetti, F, Longo, M, Piccinini, F, Neri, I, Volpe, A. L-arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Investig, 1999;6(4):202–7.Google Scholar
Cindrova-Davies, T. The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia. Front Pharmacol, 2014;5:119.Google Scholar
Fox, KA, Longo, M, Tamayo, E, et al. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol, 2011;205(4):366 e1–5.Google Scholar
Kumasawa, K, Ikawa, M, Kidoya, H, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A, 2011;108(4):1451–5.Google Scholar
Ahmed, A, Singh, J, Khan, Y, Seshan, SV, Girardi, G. A new mouse model to explore therapies for preeclampsia. PLoS One, 2010;5(10):e13663.Google Scholar
Redecha, P, van Rooijen, N, Torry, D, Girardi, G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood, 2009;113(17):4101–9.Google Scholar
NICE. National Institute for Health & Clinical Excellence: (CG37) Routine post-natal care of women and their babies. 2006.Google Scholar
Cantwell, R, Clutton-Brock, T, Cooper, G, et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG, 2011;118 Suppl 1:1–203.Google Scholar
Podymow, T, August, P, Umans, JG. Antihypertensive therapy in pregnancy. Semin Nephrol, 2004;24(6):616–25.Google Scholar
Redman, CWG, Kelly, JG, Cooper, WD. The excretion of enalapril and enalaprilat in human breast-milk. European Journal of Clinical Pharmacology, 1990;38(1):99.Google Scholar
Lunell, NO, Kulas, J, Rane, A. Transfer of labetalol into amniotic fluid and breast milk in lactating women. Eur J Clin Pharmacol, 1985;28(5):597–9.Google Scholar
Bramham, K, Nelson-Piercy, C, Brown, MJ, Chappell, LC. Postpartum management of hypertension. BMJ, 2013;346:f894.Google Scholar
Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev, 2007; 2:CD004659.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×